Search

Your search keyword '"Plk inhibitor"' showing total 9 results

Search Constraints

Start Over You searched for: Descriptor "Plk inhibitor" Remove constraint Descriptor: "Plk inhibitor"
9 results on '"Plk inhibitor"'

Search Results

1. PLK inhibitors identified by high content phenotypic screening promote maturation of human PSC-derived cardiomyocytes.

2. A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia.

Catalog

Books, media, physical & digital resources

3. Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors.

4. Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

5. Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

6. Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer.

7. A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

8. Initial testing (stage 1) of the polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program

9. Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program.